House Health Care - 2026-04-09 - 9:00AM
Committee · April 9, 2026
Discussion of S154, a proposed study of biomarker testing and its potential cost and defrayal implications; Deputy Commissioner Mary Block (DFR) urged the study be broadened and warned of potential state costs if CMS requires defrayal for mandates enacted since 2011.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No related articles available for this source.
